Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...
The S&P 500 (SP500) hit new highs during February trade, but that wasn’t enough to stave off a monthly loss. The benchmark ...
Teva's stock is a speculative buy with potential upside if biosimilars succeed, but risks remain high due to debt and ...
Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...
The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.
NORTHAMPTON, MA / / February 27, 2025 / In high-income countries, more than 80% of children diagnosed with cancer will survive. Yet in some low- and middle-income countries, this number ...
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
Parsippany, New Jersey Thursday, February 27, 2025, 13:00 Hrs [IST] ...
The application leverages existing clinical data for Uzedy along with prior FDA findings on the safety of Udezy in patients ...
Yes, we know, it's still February and yet we can't stop going on about hiking sandals, but what can we say? Our toes are ...
Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, and Medincell announced that the supplemental New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback